首页> 美国卫生研究院文献>World Journal of Gastroenterology >Relationship between LYVE-1 VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer
【2h】

Relationship between LYVE-1 VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer

机译:LYVE-1VEGFR-3和CD44基因表达与胃癌淋巴转移的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the expression levels of lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), vascular endothelial growth factor receptor-3 (VEGFR-3) and CD44 genes and the relationship between their levels and clinicopathological parameters in gastric cancer.METHODS: Tissue samples were obtained from 33 patients (8 females) with gastric cancer. mRNA levels of LYVE-1, VEGFR-3 and CD44 in normal and tumor tissues were quantitatively measured using real time polymerase chain reaction. The results were correlated with lymph node metastasis, histological type and differentiation of the tumor, T-stage, and presence of vascular, perineural and lymphatic invasions. The distribution of molecules in the tissue was evaluated using immunohistochemistry.RESULTS: LYVE-1, CD44 and VEGFR-3 gene expression levels were significantly higher in gastric cancer than in normal tissue. While there was no correlation between gene expressions and clinicopathologic features such as histologic type, differentiation and stage, gene expression levels were found to be increased in conjunction with positive lymph node/total lymph node ratio and the presence of perineural invasion. A significant correlation was also found between LYVE-1 and CD44 over-expressions and perineural invasion and lymph node positivity in gastric cancers. When the distribution of LYVE-1 antibody-stained lymphatic vessels in tissue was evaluated, lymphatic vessels were located intra-tumorally in 13% and peri-tumorally in 27% of the patients. Moreover, lymph node metastases were also positive in all patients with LYVE-1-staining.CONCLUSION: LYVE-1, VEGFR-3 and CD44 all play an important role in lymphangiogenesis, invasion and metastasis. LYVE-1 is a perfectly reliable lymphatic vessel marker and useful for immunohistochemistry.
机译:目的:探讨胃癌中淋巴管内皮透明质酸受体1(LYVE-1),血管内皮生长因子受体3(VEGFR-3)和CD44基因的表达水平及其与临床病理参数的关系。 :从33例胃癌患者(8名女性)中获取组织样本。使用实时聚合酶链反应定量测定正常和肿瘤组织中LYVE-1,VEGFR-3和CD44的mRNA水平。结果与淋巴结转移,肿瘤的组织学类型和分化,T期以及是否存在血管,神经周围和淋巴管浸润有关。结果:胃癌组织中LYVE-1,CD44和VEGFR-3基因的表达水平明显高于正常组织。尽管基因表达与临床病理特征(如组织学类型,分化和分期)之间没有相关性,但发现基因表达水平随着阳性淋巴结/总淋巴结比率和神经周围浸润的增加而增加。在胃癌中,LYVE-1和CD44的过表达与神经周浸润和淋巴结阳性之间也存在显着相关性。当评估LYVE-1抗体染色的淋巴管在组织中的分布时,淋巴管位于肿瘤内的患者中为13%,肿瘤周围为27%。此外,所有LYVE-1染色患者的淋巴结转移也均为阳性。结论:LYVE-1,VEGFR-3和CD44在淋巴管生成,侵袭和转移中均起重要作用。 LYVE-1是完全可靠的淋巴管标记物,可用于免疫组化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号